HR+ BREAST CANCER
Clinical trials for HR+ BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HR+ BREAST CANCER trials appear
Sign up with your email to follow new studies for HR+ BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New targeted drug takes on hard-to-treat breast cancers
Disease control Not yet recruitingThis study tests a new drug called SC-101 in people with advanced breast cancer that has a specific gene change (NECTIN4). The goal is to see if the drug can shrink tumors and how safe it is. About 120 adults aged 18 to 75 with triple-negative or hormone-receptor-positive breast …
Matched conditions: HR+ BREAST CANCER
Phase: PHASE2 • Sponsor: Tianjin ConjuStar Biologics Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug combo aims to boost breast cancer remission before surgery
Disease control Not yet recruitingThis study tests a new drug combination (SHR-A1811 plus pertuzumab) given before surgery for women with early or locally advanced HR-positive, HER2-positive breast cancer. The goal is to see if this treatment can eliminate all signs of cancer in the breast and lymph nodes at the …
Matched conditions: HR+ BREAST CANCER
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
CBD oil tested for breast cancer Patients' joint pain
Symptom relief Not yet recruitingThis study tests if a CBD oil drink can reduce joint pain caused by hormone therapy in people with early-stage breast cancer. About 130 participants will receive either CBD or a placebo, then switch, to see if CBD helps with pain and daily activities. The goal is to improve quali…
Matched conditions: HR+ BREAST CANCER
Phase: PHASE3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Symptom relief
Last updated May 17, 2026 04:45 UTC